The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Twenty-four-week treatment with extended release methylphenidate improves emotional symptoms in adult ADHD
Abstract
OBJECTIVES: Treatment investigations with methylphenidate in adults with ADHD focus preferentially on the classical psychopathology: inattention, hyperactivity and impulsivity. ADHD-associated emotional symptoms, which are frequently present at least in ADHD subpopulations, were studied rarely. The vast majority of the placebo-controlled trials had observation periods between 4 and 8 weeks. To assess the medium- to long-term effects of extended release methylphenidate (MPH-ER) on emotional symptoms and other psychopathology frequently seen in ADHD patients, we conducted a large-scale, multicenter treatment study. METHODS: We performed a randomised, 24-week, double-blind, placebo-controlled study in adults with ADHD. The diagnosis was made on the basis of the DSM-IV criteria, which were confirmed by clinical history and a structured psychopathological interview and the use of rating instruments. 363 patients were randomized to MPH-ER or placebo at a ratio of 2:1. The duration of the titration period was 5 weeks followed by a maintainance phase of 19 weeks. The efficacy measures were the observer rated 10-item Emotional Dysregulation Scale (EDS) derived from the Wender-Reimherr Adult Attention Deficit Disorder Scale (WRAADDS) and a self-report, six-item Emotional Lability Scale (ELS) extracted from the long version of the Conners Adult ADHD Self Report Scale (CAARS:S:L). In addition we used the SCL-90-R for the assessment of ADHD associated and comorbid psychopathology. RESULTS: MPH-ER was statistically superior to placebo in reducing emotional symptoms as assessed by the EDS and the ELS. Obsessive-compulsive symptoms and those of problems with self-concept declined until the end of the observation period. The decline was more pronounced in MPH-ER treated individuals. The effects remained robust during the entire maintenance period until week 24. Symptoms of anxiety, depression, anger and hostility, phobia, paranoid ideations and psychoticism were not improved. CONCLUSIONS: MPH-ER appears to be an efficacious treatment for emotional symptoms with ADHD. Also obsessive-compulsive symptoms and problems with self-concept were affected positively.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Psychiatric and behavioral comorbidities, such as depression, anxiety disorder, bipolar disorder, substance use, and personality disorders, often co-occur with ADHD and result in increased difficulties for appropriate diagnoses and treatments (Barkley and Brown, 2008; Rosler et al., 2010; Mao and Findling, 2014; Katzman et al., 2017).”
From A Review of Heterogeneity in Attention Deficit/Hyperactivity Disorder (ADHD) (2019) · cites this paper as Rosler et al., 2010
In the citing paper
“The effect size ranged from 0.28 to 0.4, which is lower than stimulants’ effect size on diagnostic ADHD symptoms (meta-analyses suggest a range of 0.6–0.8 [36, 37]), but it is still clinically significant.”
From Using Stimulants to Treat ADHD-Related Emotional Lability (2014) · cites this paper as [34]
In the citing paper
“Following 24 weeks of treatment with extended release methylphenidate (MPH-ER), there was a significant reduction in emotional lability, as assessed by the emotional dysregulation items on the Wender-Reimherr Adult ADHD Scale [35].”
From Using Stimulants to Treat ADHD-Related Emotional Lability (2014) · cites this paper as [34]
Citations
Cites
(1998) · Cited by 2,026
Biederman, J. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.816 · Cited by 1,498
Mannuzza, S. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820190067007 · Cited by 1,368
Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder
Fayyad, J., De Graaf, R., Kessler, R., Alonso, J., Angermeyer, M., Demyttenaere, K., De Girolamo, G., Haro, J. M., Karam, E. G., Lara, C., et al. (2007) · British Journal of Psychiatry · doi:10.1192/bjp.bp.106.034389 · Cited by 1,321
Pharmacotherapy of Attention-Deficit Hyperactivity Disorder across the Life Cycle
SPENCER, T., BIEDERMAN, J., WILENS, T., HARDING, M., O'DONNELL, D., & GRIFFIN, S. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199604000-00008 · Cited by 830
Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies
Michelson, D., Adler, L., Spencer, T., Reimherr, F. W., West, S. A., Allen, A. J., Kelsey, D., Wernicke, J., Dietrich, A., & Milton, D. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01671-2 · Cited by 790
Wïttchen, H., Wunderlich, U., Gruschwitz, S., & Zaudig, M. (1997) · Max Planck Institute for Plasma Physics · Cited by 769
WEISS, G., HECHTMAN, L., MILROY, T., & PERLMAN, T. (1985) · Journal of the American Academy of Child Psychiatry · doi:10.1016/s0002-7138(09)60450-7 · Cited by 753
ATTENTION-DEFICIT HYPERACTIVITY DISORDER IN ADULTS
Wender, P. H. (1998) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70039-3 · Cited by 728
Prevalence, Clinical Correlates, and Longitudinal Course of Severe Mood Dysregulation in Children
Brotman, M. A., Schmajuk, M., Rich, B. A., Dickstein, D. P., Guyer, A. E., Costello, E. J., EGGER, H. L., Angold, A. C., Pine, D. S., & Leibenluft, E. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.08.042 · Cited by 491
Research works printed but not linked: 2
- Biederman J, 2004, J Clin Psychiatry, 65, 3
- Weiss MD, 2004, J Clin Psychiatry, 65, 27
Cited by
Sorted by citations
Emotion Dysregulation in Attention Deficit Hyperactivity Disorder
Shaw, P., Stringaris, A., Nigg, J., & Leibenluft, E. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13070966 · Cited by 1,232
Adult ADHD and comorbid disorders: clinical implications of a dimensional approach
Katzman, M. A., Bilkey, T. S., Chokka, P. R., Fallu, A., & Klassen, L. J. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1463-3 · Cited by 732
A Review of Heterogeneity in Attention Deficit/Hyperactivity Disorder (ADHD)
Luo, Y., Weibman, D., Halperin, J. M., & Li, X. (2019) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2019.00042 · Cited by 394
Faraone, S. V., Rostain, A. L., Blader, J., Busch, B., Childress, A. C., Connor, D. F., & Newcorn, J. H. (2019) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12899 · Cited by 400
Maternal emotion and cognitive control capacities and parenting: A conceptual framework
Crandall, A., Deater-Deckard, K. D., & Riley, A. W. (2015) · Developmental Review · doi:10.1016/j.dr.2015.01.004 · Cited by 417
Adult attention-deficit hyperactivity disorder: key conceptual issues
Asherson, P., Buitelaar, J., Faraone, S. V., & Rohde, L. A. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30032-3 · Cited by 347
Bolea-Alamañac, B., Nutt, D. J., Adamou, M., Asherson, P., Bazire, S., Coghill, D., Heal, D., Müller, U., Nash, J., Santosh, P., et al. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881113519509 · Cited by 287
Emotion dysregulation in adults with attention deficit hyperactivity disorder: a meta-analysis
Beheshti, A., Chavanon, M.-L., & Christiansen, H. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-2442-7 · Cited by 247
Skirrow, C., & Asherson, P. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.10.011 · Cited by 230
Fredriksen, M., Halmøy, A., Faraone, S. V., & Haavik, J. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.07.016 · Cited by 173
Emotional dysregulation in adult ADHD: what is the empirical evidence?
Retz, W., Stieglitz, R., Corbisiero, S., Retz‐Junginger, P., & Rösler, M. (2012) · Expert Review of Neurotherapeutics · doi:10.1586/ern.12.109 · Cited by 188
Surman, C. B. H., Biederman, J., Spencer, T., Miller, C. A., McDermott, K. M., & Faraone, S. V. (2013) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-012-0100-8 · Cited by 155
Lenzi, F., Cortese, S., Harris, J., & Masi, G. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.08.010 · Cited by 141
Is emotional dysregulation part of the psychopathology of ADHD in adults?
Corbisiero, S., Stieglitz, R.-D., Retz, W., & Rösler, M. (2013) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-012-0097-z · Cited by 139
Asherson, P. J., Young, A. H., Eich‐Höchli, D., Moran, P., Porsdal, V., & Deberdt, W. G. (2014) · Current Medical Research and Opinion · doi:10.1185/03007995.2014.915800 · Cited by 140
An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults
Wilens, T. E., Morrison, N. R., & Prince, J. B. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.137 · Cited by 117
ADHD and Anxiety: Clinical Significance and Treatment Implications
Reimherr, F. W., Marchant, B. K., Gift, T. E., & Steans, T. A. (2017) · Current Psychiatry Reports · doi:10.1007/s11920-017-0859-6 · Cited by 113
ADHD in Children and Adults: Diagnosis and Prognosis
Leffa, D. T., Caye, A., & Rohde, L. A. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_329 · Cited by 127
An update on the debated association between ADHD and bipolar disorder across the lifespan
Skirrow, C., Hosang, G. M., FARMER, A. E., & Asherson, P. J. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.04.003 · Cited by 112
Corbisiero, S., Mörstedt, B., Bitto, H., & Stieglitz, R. (2016) · Journal of Clinical Psychology · doi:10.1002/jclp.22317 · Cited by 96
Zalsman, G., & Shilton, T. (2016) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501.2016.1149197 · Cited by 103
Attention-deficit/hyperactivity disorder in elite athletes: a narrative review
Han, D. H., Mcduff, D. R., Thompson, D., Hitchcock, M., Reardon, C. L., & Hainline, B. W. (2019) · British Journal of Sports Medicine · doi:10.1136/bjsports-2019-100713 · Cited by 95
Merwood, A., Chen, W., Rijsdijk, F., Skirrow, C., Larsson, H., Thapar, A., Kuntsi, J., & Asherson, P. (2014) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2013.11.006 · Cited by 84
Weyandt, L. L., Oster, D. R., Marraccini, M. E., Guðmundsdóttir, B. G., Munro, B. A., Zavras, B. M., & Kuhar, B. G. (2014) · Psychology Research and Behavior Management · doi:10.2147/prbm.s47013 · Cited by 95
Retz, W., Rösler, M., Ose, C., Scherag, A., Alm, B., Philipsen, A., Fischer, R., Ammer, R., & The Study Group (2012) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2010.540257 · Cited by 79
Using Stimulants to Treat ADHD-Related Emotional Lability
Posner, J., Kass, E., & Hulvershorn, L. (2014) · Current psychiatry reports · doi:10.1007/s11920-014-0478-4 · Cited by 66
Irritability in children and adolescents: past concepts, current debates, and future opportunities
Krieger, F., Leibenluft, E., Stringaris, A. K., & Polanczyk, G. V. (2013) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2013-s107 · Cited by 68
Fredriksen, M., Dahl, A. A., Martinsen, E. W., Klungsøyr, O., Haavik, J., & Peleikis, D. E. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.09.013 · Cited by 65
Cherkasova, M. V., French, L. R., Syer, C. A., Cousins, L. S., Galina, H., Ahmadi-Kashani, Y., & Hechtman, L. T. (2016) · Journal of Attention Disorders · doi:10.1177/1087054716671197 · Cited by 70
Lyon, G. J., Jiang, T., van Wijk, R., Wang, W., Bodily, P., Xing, J., Tian, L., Robison, R. J., Clement, M., Yang, L., et al. (2011) · PubMed · Cited by 57
Moukhtarian, T. R., Cooper, R. E., Vassos, E., Moran, P., & Asherson, P. (2017) · European Psychiatry · doi:10.1016/j.eurpsy.2017.05.021 · Cited by 56
Long-Term Outcomes with Medications for Attention-Deficit Hyperactivity Disorder
Huang, Y., & Tsai, M.-H. (2011) · CNS Drugs · doi:10.2165/11589380-000000000-00000 · Cited by 54
Skirrow, C., McLoughlin, G., Banaschewski, T., Brandeis, D., Kuntsi, J., & Asherson, P. J. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.09.015 · Cited by 50
Reimherr, F. W., Marchant, B. K., Gift, T. E., Steans, T. A., & Wender, P. H. (2015) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-015-0176-z · Cited by 59
Cadman, T., Findon, J. L., Eklund, H., Hayward, H., Howley, D., Cheung, C. H. M., Kuntsi, J., Glaser, K., Murphy, D., & Asherson, P. J. (2016) · European Psychiatry · doi:10.1016/j.eurpsy.2015.08.007 · Cited by 59
Marchant, B. K., Reimherr, F. W., Halls, C., Williams, E. D., Strong, R. E., Kondo, D. G., Soni, P., & Robison, R. J. (2011) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-011-0054-2 · Cited by 49
Exploring deficient emotion regulation in adult ADHD: electrophysiological evidence
Shushakova, A., Ohrmann, P., & Pedersen, A. (2017) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-017-0826-6 · Cited by 50
Perugi, G., Ceraudo, G., Vannucchi, G., Rizzato, S., Toni, C., & Dell'Osso, L. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.12.010 · Cited by 46
Emotion Dysregulation in Attention Deficit Hyperactivity Disorder
Shaw, P., Stringaris, A. K., Nigg, J. T., & Leibenluft, E. (2016) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.140102 · Cited by 53
Moukhtarian, T. R., Mintah, R. S., Moran, P., & Asherson, P. J. (2018) · Borderline Personality Disorder and Emotion Dysregulation · doi:10.1186/s40479-018-0086-8 · Cited by 54
The use of stimulant medications for non-core aspects of ADHD and in other disorders
Sinita, E., & Coghill, D. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.06.014 · Cited by 43
Silverstein, M. J., Faraone, S. V., Alperin, S., Leon, T. L., Biederman, J., Spencer, T. J., & Adler, L. A. (2018) · Journal of Attention Disorders · doi:10.1177/1087054718756198 · Cited by 43
Addressing the lack of studies in attention-deficit/hyperactivity disorder in adults
Ramos‐Quiroga, J. A., Nasillo, V., Fernández‐Aranda, F., & Casas, M. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.908708 · Cited by 44
Villemonteix, T., Purper‐Ouakil, D., & Romo, L. (2014) · L Encéphale · doi:10.1016/j.encep.2013.12.004 · Cited by 48
Neurobiological and psychophysiological correlates of emotional dysregulation in ADHD patients
Herrmann, M. J., Biehl, S. C., Jacob, C., & Deckert, J. (2010) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-010-0047-6 · Cited by 42
Vidal, R., Valero, S., Nogueira, M., Palomar, G., Corrales, M., Richarte, V., Bosch, R., Gómez-Barros, N., Corominas, M., Casas, M., et al. (2014) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2014.07.001 · Cited by 36
Pharmacological treatment of adult ADHD in Europe
Retz, W., Retz‐Junginger, P., Thome, J., & Rösler, M. (2011) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.603229 · Cited by 37
Ben-Dor Cohen, M., Eldar, E., Maeir, A., & Nahum, M. (2021) · Health and Quality of Life Outcomes · doi:10.1186/s12955-021-01904-8 · Cited by 35
The use of stimulants and atomoxetine in adults with comorbid ADHD and bipolar disorder
Perugi, G., & Vannucchi, G. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1079620 · Cited by 38
Gamlı, İ. S., & Tahiroğlu, A. Y. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s164807 · Cited by 35
Violent offending in borderline personality disorder and attention deficit/hyperactivity disorder
Sebastian, A., Retz, W., Tüscher, O., & Turner, D. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.03.008 · Cited by 35
Perugi, G., Pallucchini, A., Rizzato, S., Pinzone, V., & Rossi, P. D. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1618270 · Cited by 35
Lensing, M. B., Zeiner, P., Sandvik, L., & Opjordsmoen, S. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12m07714 · Cited by 32
Fredriksen, M., & Peleikis, D. E. (2015) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12477 · Cited by 31
Retz, W., & Retz‐Junginger, P. (2014) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-014-0542-4 · Cited by 34
Sobanski, E., Retz, W., Fischer, R., Ose, C., Alm, B., Hennig, O., & Rösler, M. (2014) · European psychiatry · doi:10.1016/j.eurpsy.2013.08.004 · Cited by 32
Pharmacological treatment of attention-deficit/hyperactivity disorder: assessing outcomes
Adamo, N., Seth, S., & Coghill, D. (2015) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2015.1050379 · Cited by 31
Rösler, M., Ginsberg, Y., Arngrim, T., Adamou, M., Niemelä, A., Dejonkheere, J., van Oene, J., & Schäuble, B. (2011) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.571283 · Cited by 28
Giakoumatos, C. I., & Osser, D. N. (2019) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000197 · Cited by 27
Mörstedt, B., Corbisiero, S., Bitto, H., & Stieglitz, R. (2015) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-015-0181-2 · Cited by 26
Asherson, P. J., Stes, S., Markhed, M. N., Berggren, L., Svanborg, P., Kutzelnigg, A., & Deberdt, W. G. (2015) · European Psychiatry · doi:10.1016/j.eurpsy.2014.12.002 · Cited by 25
Attention-deficit/hyperactivity disorder in adults: update on clinical presentation and care
Asherson, P. J., Manor, I., & Huß, M. (2014) · Neuropsychiatry · doi:10.2217/npy.14.16 · Cited by 27
Childress, A. C., & Sallee, F. R. (2015) · CNS Drugs · doi:10.1007/s40263-015-0264-9 · Cited by 23
Methylphenidate HCL for the treatment of ADHD in children and adolescents
Childress, A. C. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2016.1182986 · Cited by 23
Ventura, P., de Giambattista, C., Trerotoli, P., Cavone, M., Di Gioia, A., & Margari, L. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11102922 · Cited by 22
Ramos‐Quiroga, J. A., Corominas, M., Gloria Palomar, A., Ferrer, R., Valero, S., Montse Corrales, F., Vanesa Richarte, B., & Casas, M. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.03.014 · Cited by 19
Asherson, P. J., Johansson, L. C., Holland, R., Fahy, T., Forester, A., Howitt, S., Lawrie, S. M., Strang, J., Young, S., Landau, S., et al. (2019) · Trials · doi:10.1186/s13063-019-3705-9 · Cited by 18
Liu, T., Hsiao, R. C.-J., Chou, W., & Yen, C. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18136872 · Cited by 18
Identifying different patterns of emotion dysregulation in adult ADHD
Martz, É., Weiner, L., & Weibel, S. (2023) · Borderline Personality Disorder and Emotion Dysregulation · doi:10.1186/s40479-023-00235-y · Cited by 25
Liu, T., Hsiao, R. C.-J., Chou, W., & Yen, C. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18157829 · Cited by 28
Brancati, G. E., Acierno, D., Barbuti, M., Elefante, C., Gemignani, S., Raia, A., & Perugi, G. (2023) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2023.2263645 · Cited by 16
Psychometric Properties of the Self-Report Wender-Reimherr Adult Attention Deficit Disorder Scale
Marchant, B. K., Reimherr, F. W., Wender, P. H., & Gift, T. E. (2015) · Annals of Clinical Psychiatry · doi:10.1177/104012371502700406 · Cited by 16
Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults
Boesen, K., Paludan‐Müller, A. S., Gøtzsche, P. C., & Jørgensen, K. J. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012857.pub2 · Cited by 23
Stimulants, cognition and ADHD
Baroni, A., & Castellanos, F. X. (2015) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2015.04.010 · Cited by 14
The Impact of Emotional Lability Symptoms During Childhood in Adults With ADHD
Gisbert, L., Vanesa Richarte, B., Montse Corrales, F., Ibáñez, P., Bosch, R., Casas, M., & Ramos‐Quiroga, J. A. (2017) · Journal of Attention Disorders · doi:10.1177/1087054717719534 · Cited by 16
The Relationship Between Neuropsychological Deficits and Emotional Lability in Adults With ADHD
Gisbert, L., Vanesa Richarte, B., Montse Corrales, F., Ibáñez, P., Bosch, R., Bellina, M., Fadeuilhe, C., Casas, M., & Ramos‐Quiroga, J. A. (2018) · Journal of Attention Disorders · doi:10.1177/1087054718780323 · Cited by 14
Methylphenidate–risperidone combination in child psychiatry: A retrospective analysis of 44 cases
Javelot, H., Glay-Ribau, C., Ligier, F., Weiner, L., Didelot, N., Messaoudi, M., Socha, M., Lawson, F. B., & Kabuth, B. (2014) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2013.12.009 · Cited by 13
Kvadsheim, E., Fasmer, O. B., Osnes, B., Koenig, J., Adólfsdóttir, S., Eichele, H., Plessen, K. J., & Sørensen, L. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00244 · Cited by 11
Relationship Between ADHD-Like Traits and Emotion Dysregulation in the Adult General Population
Albesisi, S., & Overton, P. G. (2023) · Advances in Neurodevelopmental Disorders · doi:10.1007/s41252-023-00381-y · Cited by 13
Duygular ve Psikolojik Belirtiler Arasındaki İlişkiler
Vatan, S. (2016) · Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry · doi:10.18863/pgy.281117 · Cited by 15
Methylphenidate and emotional-motivational processing in attention-deficit/hyperactivity disorder
Conzelmann, A., Woidich, E., Mucha, R. F., Weyers, P., Müller, M., Lesch, K., Jacob, C., & Pauli, P. (2016) · Journal of Neural Transmission · doi:10.1007/s00702-016-1512-y · Cited by 10
Pharmacologic and non-pharmacologic interventions for emotional lability: A meta-analysis
Agapoff, J. R., Zhang, C., Meek, M., & van Schalkwyk, G. I. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105184 · Cited by 9
ADHD and Nicotine Use in Schizophrenia or Asperger Syndrome
Hallerbäck, M. U., Lugnegård, T., & Gillberg, C. (2012) · Journal of Attention Disorders · doi:10.1177/1087054712439099 · Cited by 9
Alpizar, A. (2019) · Revista Costarricense de Psicología · doi:10.22544/rcps.v38i01.02 · Cited by 8
Pallucchini, A., Carli, M., Maremmani, A. G. I., Scarselli, M., Perugi, G., & Maremmani, I. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10091984 · Cited by 9
Drug Class Review: Pharmacologic Treatments for Attention Deficit Hyperactivity Disorder
McDonagh, M. S., & Peterson, K. (2011) · Cited by 7
Emotional dysregulation and stimulant medication in adult ADHD
Greenfield, M. S., Wang, Y., Hamilton, J. P., Thunberg, P., & Msghina, M. (2024) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.240009 · Cited by 10
Surman, C. B. H., & Walsh, D. M. (2023) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.2209 · Cited by 8
Ramsay, J. R., & Rostain, A. L. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781139035491.030 · Cited by 6
Do Treatments for Adult ADHD Improve Emotional Behavior? A Systematic Review and Analysis
Surman, C. B. H., & Walsh, D. M. (2022) · Journal of Attention Disorders · doi:10.1177/10870547221110926 · Cited by 6
Medikamentöse Therapie der Aufmerksamkeitsdefizit‑/Hyperaktivitätsstörung im Erwachsenenalter
Retz, W., Retz‐Junginger, P., Davydenko, S., & Rösler, M. (2020) · Der Nervenarzt · doi:10.1007/s00115-020-00891-3 · Cited by 5
Dikkat Eksikliği ve Hiperaktivite Bozukluğunda Duygu Düzenleme Güçlükleri ve Tedavisi
Öztürk, Y., Özyurt, G., Tufan, A. E., & Pekcanlar, A. A. (2017) · Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry · doi:10.18863/pgy.358101 · Cited by 9
ADHD in Adults: A Clinical Concern
Asherson, P. J. (2012) · Humana Press eBooks · doi:10.1007/978-1-62703-248-3_1 · Cited by 7
Managing ADHD in Adults with Common Comorbidities
Sobanski, E., Paslakis, G., Schredl, M., Daffner, S., & Alm, B. (2012) · Humana Press eBooks · doi:10.1007/978-1-62703-248-3_8 · Cited by 6
Purper‐Ouakil, D., Vacher, C., & Villemonteix, T. (2014) · Annales Médico-psychologiques revue psychiatrique · doi:10.1016/j.amp.2014.03.004 · Cited by 4
Tripodi, B., Carbone, M. G., Matarese, I., Rizzato, R., Rocca, F. D., Dominicis, F. D., & Callegari, C. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14248848 · Cited by 4
OROS-methylphenidate to reduce ADHD symptoms in male prisoners aged 16–25 years: a RCT
Asherson, P. J., Johansson, L., Holland, R., Bedding, M., Forrester, A., Giannulli, L., Ginsberg, Y., Howitt, S., Kretzschmar, I., Lawrie, S. M., et al. (2022) · Efficacy and Mechanism Evaluation · doi:10.3310/thei8200 · Cited by 4
López-Pinar, C., Selaskowski, B., Braun, N., Fornés, V., Euscher, R., Matthies, S., Jans, T., van Elst, L. T., Jacob, C., Huß, M., et al. (2023) · Psychiatry Research · doi:10.1016/j.psychres.2023.115610 · Cited by 4
Riechmann, E., Sattler, F. A., Christiansen, H., & Chavanon, M. (2017) · Lernen und Lernstörungen · doi:10.1024/2235-0977/a000178 · Cited by 3
An, Y., Song, Y., & Kang, U. G. (2022) · 신경정신의학 · doi:10.4306/jknpa.2022.61.2.45 · Cited by 3
Metadata
- Authors
- Rösler, M., Retz, W., Fischer, R., Ose, C., Alm, B., Deckert, J., Philipsen, A., Herpertz, S., & Ammer, R.
- Affiliations
- Universitätsklinikum des Saarlandes (DE)
- Medice (Germany) (DE)
- Institut für Medizinische Informatik, Biometrie und Epidemiologie (DE)
- Central Institute of Mental Health (DE)
- University of Würzburg (DE)
- University of Freiburg (DE)
- University of Rostock (DE)
- Corresponding author
- Rösler, Michael
- ORCID
- Venue
- The World Journal of Biological Psychiatry
- Publisher
- Informa UK Limited
- Published
- 2010-03-30
- Volume
- 11
- Issue
- 5
- Pages
- 709-718
- ISSN
- 1562-2975 (ISSN-L)
- 1814-1412
- OpenAlex
- W1985528539
- Cited by
- 131
- References
- 43
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 1 · 2023: 6 · 2022: 8 · 2021: 7 · 2020: 8 · 2019: 7 · 2018: 6 · 2017: 11 · 2016: 13 · 2015: 11 · 2014: 20 · 2013: 7 · 2012: 9
- FWCI
- 5.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The World Journal of Biological Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- adult ADHD, extended-release methylphenidate, emotional symptoms, emotional dysregulation, emotional lability, obsessive-compulsive symptoms, self-concept, long-term treatment efficacy, comorbid psychopathology
- MeSH terms
- Adult, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Delayed-Action Preparations, Double-Blind Method, Emotions, Female, Follow-Up Studies, Humans, Long-Term Care, Male, Methylphenidate, Middle Aged, Obsessive-Compulsive Disorder, Personality Assessment, Psychometrics, Treatment Outcome, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review